Relationship of the expression of bcl-2 and bad in breast cancer cell with chemosensitivity

LUO Jie; et al

您当前的位置：

首页 >

文章列表页 >

Relationship of the expression of bcl-2 and bad in breast cancer cell with chemosensitivity

更新时间：2024-01-17

- Relationship of the expression of bcl-2 and bad in breast cancer cell with chemosensitivity
- Journal of Chongqing Medical University Vol. 34, Issue 12, Pages: 1651-1654(2009)
- 作者机构：
  
  重庆医科大学附属第二医院普外科
- 作者简介：
- 基金信息：
- DOI：
  CLC： R737.9
- Published：2009，
扫描看全文
[1]罗杰,于冰,孙治君.Bcl-2、Bad表达与乳腺癌细胞对化疗药物敏感性的关系[J].重庆医科大学学报,2009,34(12):1651-1654.

LUO Jie, et al. Relationship of the expression of bcl-2 and bad in breast cancer cell with chemosensitivity. [J]. Journal of Chongqing Medical University 34(12):1651-1654(2009)
[1]罗杰,于冰,孙治君.Bcl-2、Bad表达与乳腺癌细胞对化疗药物敏感性的关系[J].重庆医科大学学报,2009,34(12):1651-1654. DOI：

LUO Jie, et al. Relationship of the expression of bcl-2 and bad in breast cancer cell with chemosensitivity. [J]. Journal of Chongqing Medical University 34(12):1651-1654(2009) DOI：

摘要

目的:研究bcl-2、bad表达与乳腺癌细胞对化疗药物敏感性的关系。方法:选取术中冰冻病理诊断为乳腺癌（术前未行放疗、化疗）的手术切除标本20例

体外分离细胞作培养

应用四甲基偶氮唑盐（3-（4

5-Dimethylthiazol-2-yl）-2

5-diphenylt etrazolium bromide

MTT）法分析表柔比星（Epirubicin adriamycin

EADM）、5-氟脲嘧啶（Fluorouracil

5-Fu）、盖诺（Navelbine

NVB）、顺铂（Diaminedichloroplatinum

DDP）4种化疗药物对乳腺癌肿瘤细胞的相对抑制率

通过免疫组织化学染色法分析乳腺癌组织bcl-2、bad的表达。结果:0.1倍血浆峰值浓度（Plasma peak concentration

PPC）浓度时乳腺癌细胞对4种化疗药物的敏感率分别为EADM30%、5-Fu20%、NVB45%、DDP25%;bcl-2（-）的乳腺癌细胞对4种化疗药物敏感性均高于bcl-2（+）的乳腺癌细胞（P<0.05）

bcl-2阳性表达程度与乳腺癌细胞对化疗药物的敏感性存在负相关关系（P<0.05）。bad（+）的乳腺癌细胞对EADM敏感性高于bad（-）的乳腺癌细胞（P<0.05）

bad阳性表达程度与乳腺癌细胞对EADM、NVB的敏感性存在正相关关系（P<0.05）。结论:联合检测bcl-2、bad的表达可对乳腺癌化疗药物的选择起到指导作用

调节bcl-2、bad表达水平能成为治疗乳腺癌的新途径。

Abstract

Objective:To investigate the relationship of the expression of bcl-2 and bad in breast cancer cells with chemosensitivity.Methods:Surgical samples of breast cancer

diagnosed by pathology

were obtained from The First Affiliated Hospital of Chongqing Medical University.The cancer sample cells were cultured separately in the incubator at 37℃

5% CO2 in vitro.The rate of inhibition of cancer cells by 4 kindsof anticancer drugs

which were EADM(Epirubicin adriamycin)

5-Fu(Fluorouracil)

NVB(Navelbine) and DDP(Diaminedichloroplatinum)

were assayed by MTT(3-(4

5-Dimethylthiazol-2-yl)-2

5-diphenyltetrazolium bromide)method.Immuno histochemistry was used to detect the expression of IL-2 and IL-4 in the breast cancer tissues.Results:Sensitivity rates of 20 breast cancer cells in 0.1×PPC(plasma peak concentration) within 48h in vitro were 30%(EADM)

20%(5-Fu)

45%(NVB)and 25%(DDP).Respectively the rate of inhibition of EADM

5-Fu

NVB and DDP were significantly higher in the bcl-2 negative cancer cells than in the bcl-2 positive cancer cells.A negative correlation was found between expression of bcl-2 and chemosensitivity for all the 4 anticancer drugs.The rates of inhibition of EADM and NVB were significantly lower in the bad negative cancer cells than in the bad positive cancer cells.A positive correlation was found between expression of bad and chemosensitivity for EADM.Conclusion:The combined detection of bcl-2 and bad may be taken as an index of the selection of anticancer drugs.Regulated the expression level of bcl-2 and bad may be a new way to the therapy of breast cancer.

关键词

乳腺癌Bcl-2Bad化疗敏感性

Keywords

breast cancerBcl-2Badchemosensitivity

references

Views

166

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Relationship of the expression of IL-2 and IL-4 in breast cancer with chemosensitivity

Pathomics signature based on machine learning can predict the response to neoadjuvant chemotherapy in breast cancer patients

Effects of circular RNA hsa_circ_0002185 on cell viability and invasion of breast cancer cells and its mechanism of action

Prediction and identification of H-2Kd restricted CTL epitope derived from breast cancer associated antigen ROR1

Comparison of lung dosimetry between supine and sternal horizon positions during X-ray irradiated radical mastectomy radiation therapy

Related Author

YU Bing

et al

沈洪彦

Zhang Jieqiu

Wu Qi

Wang Jianmei

Yao Xiaopeng

Shaojie Qin

Related Institution

Department of General Surgery,The First Affiliated Hospital,Chongqing Medical University

Department of Epidemiology and Health Statistics， School of Public Health，Southwest Medical University

Department of Pathology，The Affiliated Hospital of Southwest Medical University

Department of Medical Engineering Technology，School of Medical Information and Engineering，Southwest Medical University

Oncological Surgery Third Department, General Hospital of Ningxia Medical University

⁰